Larvol Delta - LongTerm-Outcomes-with-Lecanemab-in-Early-Alzheimer39s-Disease-Initial-Findings-Through-60Months-of-Clarity-AD-OpenLabel-Extension

Gazyva (obinutuzumab) - Roche, Biogen

http://clinicaltrials.gov/ct2/show/NCT07842523

Sep 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next